Current and Emerging Targets in Immunotherapy for Osteosarcoma

Osteosarcoma is the most common primary malignancy of bone. Although outcomes of patients with osteosarcoma have improved since the introduction of chemotherapy, outcomes of metastatic or unresectable osteosarcomas are still unsatisfactory. To improve osteosarcoma outcomes, the development of novel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Oncol
Glavni autori: Miwa, Shinji, Shirai, Toshiharu, Yamamoto, Norio, Hayashi, Katsuhiro, Takeuchi, Akihiko, Igarashi, Kentaro, Tsuchiya, Hiroyuki
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2019
Teme:
Review Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332920/
https://ncbi.nlm.nih.gov/pubmed/30693030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7035045
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items